Oncology Corporate Profile
Heat Biologics, Inc. is a clinical-stage biopharmaceutical company focused on developing its novel, "off-the-shelf" ImPACT therapeutic vaccines to combat a wide range of cancers. Their ImPACT Therapy is designed to deliver live, genetically-modified, irradiated human cells which are reprogrammed to "pump out" a broad spectrum of cancer-associated antigens together with a potent immune adjuvant called "gp96" to educate and activate a cancer patient's immune system to recognize and kill cancerous cells.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|vesigenurtucel-L / HS-410||cytotoxic t-cell specific adjuvant||Bladder cancer||II|
|vesigenurtucel-L (+nivolumab) / HS-110||cytotoxic t-cell specific adjuvant||Non Small Cell Lung Cancer (NSCLC)||II|
|vesigenurtucel-L (+cyclophosphamide) / HS-110||cytotoxic t-cell specific adjuvant||Non Small Cell Lung Cancer (NSCLC)||II|
View additional information on product candidates here »